Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
In the context of Escherichia coli Nissle 1917 / E. coli Nissle 1917 & Ulcerative Colitis (UC), the European Society of Nutrition and Metabolism also recommended Escherichia coli Nissle 1917 as drug for the treatment of mild to moderate Ulcerative Colitis (UC), suggesting that probiotics do have therapeutic potential for Ulcerative Colitis (UC) (1).
[Escherichia coli Nissle 1917 / E. coli Nissle 1917 (EcN)](brain://UId7zu6cjked389OpfK0BQ/EscherichiaColiNissle1917ECol…